SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies? | Dr Med - University of Zagreb School of Medicine Digital Repository

prikaz prve stranice dokumenta SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?

Download
PDF 359.85 KB

Professional paper - Letter to the editor

SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?

British Journal of Clinical Pharmacology, 87 (2021), 11; 4476-4478. https://doi.org/10.1111/bcp.14849

Bošković, Marko; Migo, William; Likić, Robert

Linked objects

COVID-19 | Virtual collection

Cite this document

APA 6th Edition

Bošković, M., Migo, W. & Likić, R. (2021). SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?. British Journal of Clinical Pharmacology, 87. (11), 4476-4478. doi: 10.1111/bcp.14849

MLA 8th Edition

Bošković, Marko, et al. "SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?." British Journal of Clinical Pharmacology, vol. 87, no. 11, 2021, pp. 4476-4478. https://doi.org/10.1111/bcp.14849

Chicago 17th Edition

Bošković, Marko, William Migo and Robert Likić. "SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?." British Journal of Clinical Pharmacology 87, no. 11 (2021): 4476-4478. https://doi.org/10.1111/bcp.14849

Harvard

Bošković, M., Migo, W. and Likić, R. (2021) 'SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?', British Journal of Clinical Pharmacology, 87(11), pp. 4476-4478. doi: 10.1111/bcp.14849

Vancouver

Bošković M, Migo W, Likić R. SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?. British Journal of Clinical Pharmacology [Internet]. 2021 November [cited 2024 April 19];87(11):4476-4478. doi: 10.1111/bcp.14849

IEEE

M. Bošković, W. Migo and R. Likić, "SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?", British Journal of Clinical Pharmacology, vol. 87, no. 11, pp. 4476-4478, November 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:329087. [Accessed: 19 April 2024]

Cite this item: https://urn.nsk.hr/urn:nbn:hr:105:329087

Please login to the repository to save this object to your list.

Metadata

Title (english)	SARS‐CoV‐2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
Author	Marko Bošković
Author	William Migo
Author	Robert Likić
Author's institution	University of Zagreb School of Medicine
Scientific / art field, discipline and subdiscipline	BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Internal Medicine
Keywords (english)
Language	english
Publication type	Professional paper - Letter to the editor
Publication status	Published
Peer review	Peer review
Publication version	Published version
Journal title	British Journal of Clinical Pharmacology
Numbering	vol. 87, no. 11, pp. 4476-4478
p-ISSN	0306-5251
e-ISSN	1365-2125
DOI	https://doi.org/10.1111/bcp.14849
URN:NBN	urn:nbn:hr:105:329087
Publication	2021-11
Document URL	https://onlinelibrary.wiley.com/doi/10.1111/bcp.14849
Type of resource	Text
Access conditions	Open access
Terms of use
Created on	2021-12-09 12:18:15